Jefferies Financial Group Inc. Has $12.67 Million Stock Holdings in Cencora, Inc. $COR

Jefferies Financial Group Inc. decreased its position in shares of Cencora, Inc. (NYSE:COR) by 20.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 40,551 shares of the company’s stock after selling 10,155 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Cencora were worth $12,673,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of COR. IAG Wealth Partners LLC bought a new stake in shares of Cencora in the third quarter valued at about $30,000. Cloud Capital Management LLC bought a new position in Cencora during the third quarter worth about $31,000. Caitlin John LLC bought a new position in Cencora during the third quarter worth about $31,000. Vermillion & White Wealth Management Group LLC raised its stake in Cencora by 69.4% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after purchasing an additional 43 shares in the last quarter. Finally, Westside Investment Management Inc. raised its stake in Cencora by 200.0% in the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after purchasing an additional 70 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on COR. Weiss Ratings raised shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a report on Thursday, February 5th. Robert W. Baird set a $415.00 price target on shares of Cencora in a research report on Tuesday, January 13th. JPMorgan Chase & Co. boosted their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. Bank of America reduced their price target on Cencora from $380.00 to $360.00 and set a “neutral” rating on the stock in a research report on Monday, January 5th. Finally, Barclays raised their price objective on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Eleven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $399.00.

Cencora Trading Down 0.4%

Shares of Cencora stock opened at $357.98 on Monday. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. Cencora, Inc. has a 12-month low of $251.94 and a 12-month high of $377.54. The company has a market capitalization of $69.64 billion, a price-to-earnings ratio of 43.03, a PEG ratio of 1.67 and a beta of 0.68. The firm’s 50-day moving average price is $354.16 and its two-hundred day moving average price is $336.68.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. During the same period in the previous year, the company earned $3.73 EPS. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. On average, analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is 28.85%.

Insider Buying and Selling at Cencora

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of the business’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $342.10, for a total value of $1,146,377.10. Following the sale, the executive vice president owned 23,891 shares of the company’s stock, valued at $8,173,111.10. The trade was a 12.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,220 shares of company stock worth $5,282,867 over the last three months. Corporate insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.